The global Pharmaceutical Grade Cannabis market size is predicted to grow from US$ 990 million in 2025 to US$ 1526 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.

Pharmaceutical grade cannabis is a term used to describe cannabis products that meet the high-quality and safety standards required for pharmaceutical use. This designation implies that the cannabis has been cultivated, processed, and tested in a manner consistent with pharmaceutical regulations and guidelines.

Legalization and Regulation: Many countries and states were moving towards the legalization and regulation of medical cannabis. This trend was expected to continue, opening up new markets for pharmaceutical-grade cannabis products.

Clinical Trials: Pharmaceutical companies and research institutions were conducting clinical trials to evaluate the safety and efficacy of cannabis-based medications for various medical conditions, including chronic pain, epilepsy, multiple sclerosis, and more.

Product Diversification: The market was witnessing the development of a wide range of pharmaceutical-grade cannabis products, including capsules, tinctures, transdermal patches, and inhalers. These products were designed to provide consistent dosing and delivery methods.

Quality Control: As the pharmaceutical-grade cannabis market matured, there was a greater emphasis on quality control and standardization of production processes. Ensuring product consistency and purity was a top priority.

International Expansion: Companies were exploring opportunities to expand into international markets as more countries considered legalizing medical cannabis. Exporting pharmaceutical-grade cannabis products to countries with established medical cannabis programs became a strategic focus for some companies.

Infinity Market Research newest research report, the ?Pharmaceutical Grade Cannabis Industry Forecast? looks at past sales and reviews total world Pharmaceutical Grade Cannabis sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Cannabis sales for 2025 through 2031. With Pharmaceutical Grade Cannabis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Cannabis industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Cannabis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Cannabis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pharmaceutical Grade Cannabis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Cannabis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Cannabis.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Cannabis market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Dronabinol
    Nabilone
    Nabiximols
    Cannabidiol
    Others

Segmentation by Application:

    Oral Medications
    Topical Medications

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Ultra Health
    Mammoth Farms
    Palo Verde Center
    Hexo Corp
    Bright Green Corporation
    Copperstate Farms
    Los Suenos Farms
    Canna
    Village Farms
    Aurora
    Canopy Growth
    Cresco Labs
    Glass House Farms
    Organigram
    C3 International
    CannTrust
    FlowerOne
    Solaris Farms
    7Acres
    ThePharm

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Grade Cannabis market?
What factors are driving Pharmaceutical Grade Cannabis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Grade Cannabis market opportunities vary by end market size?
How does Pharmaceutical Grade Cannabis break out by Type, by Application?